MGMT and glioblastoma: MGMT-methylated tumors: A European Organisation for Research and Treatment of Cancer (EORTC)/National Cancer Institute of Canada (NCIC) open-label trial was the first to show that concurrent and adjuvant treatment with temozolomide was effective in adults with glioblastoma.